Association of sex and age with the ceramide profile of adipose tissue in patients with coronary artery disease

Authors:

Abstract
Background . Coronary artery disease (CAD) is associated with complex molecular changes in adipose tissue (AT) that go beyond simple energy storage. Current studies indicate the active participation of AT in metabolic regulation and secretion of bioactive lipid mediators, including ceramides, the role of which in CAD pathogenesis remains poorly understood, particularly with regard to age and sex differences. Aim. To characterize the ceramide profile in subcutaneous, epicardial and perivascular AT (SAT, EAT, PVAT) in patients with CAD, with regard to age and sex differences. Materials and Methods . A lipidomic study of the ceramide profile was conducted in SAT, EAT, PVAT samples obtained from 58 patients with CAD who underwent coronary artery bypass grafting (single-center prospective clinical study). The ceramide composition was analyzed by high-performance liquid chromatography with tandem mass spectrometric detection. Results . Ageand sex-related differences in the AT ceramide profile were identified. In men, the concentrations of cardionegative ceramides (Cer d18:1/14:0, Cer d18:1/18:0, Cer d18:1/20:0, Cer d18:1/22:0) and Cer d18:1/24:1 were higher (p < 0.05). In PVAT of men, the levels of Cer 14:0, 16:0 and 22:4 were increased (p < 0.001). In EAT and PVAT of women, increased levels of Cer 18:0 and 23:0 were noted (p < 0.05). In EAT and PAT of women, the concentrations of Cer 20:0, 22:0 and 24:1 were higher (p < 0.05). The highest levels of cardionegative ceramides were observed in PVAT of patients aged over 75 years. The ratio of cardionegative to cardioprotective ceramides was higher in EAT in individuals aged 60–74 years and in PVAT in those aged over 75 years. Conclusion. Significant sexand age-related differences in the AT ceramide profile of patients with CAD were identified, emphasizing the need to consider these factors when assessing cardiovascular risk. The data obtained may contribute to the development of new therapeutic strategies aimed at modulating the ceramide profile of AT to reduce cardiovascular risk.

This publication has 23 references indexed in Scilit: